catalpol has been researched along with Palmoplantaris Pustulosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, A; Tu, Y; Wang, Q; Zhang, B; Zhao, W | 1 |
1 other study(ies) available for catalpol and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.
Topics: Animals; Dermatologic Agents; Disease Models, Animal; HaCaT Cells; Humans; Interleukins; Iridoid Glucosides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis; Sirtuin 1; Skin | 2021 |